lysergic acid diethylamide has been researched along with Lymphoma, Non-Hodgkin in 1 studies
Lysergic Acid Diethylamide: Semisynthetic derivative of ergot (Claviceps purpurea). It has complex effects on serotonergic systems including antagonism at some peripheral serotonin receptors, both agonist and antagonist actions at central nervous system serotonin receptors, and possibly effects on serotonin turnover. It is a potent hallucinogen, but the mechanisms of that effect are not well understood.
lysergic acid diethylamide : An ergoline alkaloid arising from formal condensation of lysergic acid with diethylamine.
Lymphoma, Non-Hodgkin: Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
SCOTT, KG | 1 |
DANIELS, AE | 1 |
1 other study available for lysergic acid diethylamide and Lymphoma, Non-Hodgkin
Article | Year |
---|---|
THE SIMILAR ACTION OF LYSERGIC ACID DERIVATIVES, HYPERTENSIN (CIBA) AND ALDOSTERONE UPON RB86 UPTAKE BY RED BLOOD CELLS FROM CONTROL AND CANCER SUBJECTS.
Topics: Adenocarcinoma; Aldosterone; Angiotensin Amide; Angiotensins; Carcinoma, Squamous Cell; Erythrocytes | 1963 |